| scholarly article | Q13442814 |
| P356 | DOI | 10.1006/JSRE.1997.5071 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:S002248049795071X?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:S002248049795071X?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 9237883 |
| P2093 | author name string | H. A. Reber | |
| S. W. Ashley | |||
| D. W. McFadden | |||
| A. J. Rongione | |||
| A. M. Kusske | |||
| P2860 | cites work | Interleukin-10 | Q28263225 |
| Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin | Q28306447 | ||
| Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes | Q29619621 | ||
| Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia | Q34173960 | ||
| Interleukin 1: the first interleukin. | Q34372820 | ||
| Identification of an inducible endothelial-leukocyte adhesion molecule | Q34381169 | ||
| Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia | Q36357020 | ||
| A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice | Q36360996 | ||
| Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia | Q36361322 | ||
| Interleukin 10 protects mice from lethal endotoxemia | Q36361558 | ||
| The pathogenesis of sepsis | Q37251283 | ||
| Current perspectives on septic shock | Q39755512 | ||
| Current management of the septic shock patient: experimental basis for treatment | Q40248603 | ||
| Sepsis and septic shock--a review of laboratory models and a proposal | Q40290200 | ||
| Anticytokine strategies in the treatment of the systemic inflammatory response syndrome | Q40890292 | ||
| Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits | Q41017625 | ||
| A specific receptor antagonist for interleukin 1 prevents Escherichia coli ‐induced shock in rabbits | Q43740171 | ||
| Lymphocyte macrophage interactions in the response to surgical infections | Q44251568 | ||
| Divergent efficacy of antibody to tumor necrosis factor-alpha in intravascular and peritonitis models of sepsis | Q44493988 | ||
| Interleukin 10 reduces the severity of acute pancreatitis in rats | Q46054174 | ||
| Biological properties of interleukin 10 | Q56987728 | ||
| Interleukin-1 receptor antagonist reduces mortality from endotoxin shock | Q59092106 | ||
| The Complex Pattern of Cytokines in Sepsis Association Between Prostaglandins, Cachectin, and Interleukins | Q60157035 | ||
| Nitric oxide mediates tumor necrosis factor-alpha cytotoxicity in endothelial cells | Q67539821 | ||
| Plasma level of tumor necrosis factor in disseminated intravascular coagulation | Q67924195 | ||
| Tumor necrosis factor induces adult respiratory distress syndrome in rats | Q69391781 | ||
| Differential expression of interleukin-1 and tumor necrosis factor in murine septic shock models | Q69405216 | ||
| Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans | Q69748429 | ||
| Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease | Q69893443 | ||
| Immunologic activation of hepatic macrophages in septic rats: a possible mechanism of sepsis-associated liver injury | Q72304112 | ||
| Regulation of macrophage TNF alpha, IL-1 beta, and Ia (I-A alpha) mRNA expression during peritonitis is site dependent | Q72902754 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | sepsis | Q183134 |
| P304 | page(s) | 107-112 | |
| P577 | publication date | 1997-07-01 | |
| P1433 | published in | Journal of Surgical Research | Q15763329 |
| P1476 | title | Interleukin-10 prevents early cytokine release in severe intraabdominal infection and sepsis | |
| Interleukin-10 Prevents Early Cytokine Release in Severe Intraabdominal Infection and Sepsis | |||
| P478 | volume | 70 |
| Q50182009 | A comparative study of angiogenic and cytokine responses after laparoscopic cholecystectomy performed with standard- and low-pressure pneumoperitoneum |
| Q35718469 | Active Negative Pressure Peritoneal Therapy After Abbreviated Laparotomy: The Intraperitoneal Vacuum Randomized Controlled Trial. |
| Q48679159 | Carbon dioxide pneumoperitoneum prevents mortality from sepsis |
| Q81185969 | Change of TH1/TH2 cytokine equilibrium in rats with severe sepsis and therapeutic effect of recombinant interleukin-12 and Shenmai injection |
| Q55499573 | Closed Or Open after Source Control Laparotomy for Severe Complicated Intra-Abdominal Sepsis (the COOL trial): study protocol for a randomized controlled trial. |
| Q43507292 | Differential effects of pentoxifylline, a non-specific phosphodiesterase inhibitor, on the production of IL-10, IL-12 p40 and p35 subunits by murine peritoneal macrophages |
| Q30429758 | Dysregulation of inflammatory responses by chronic circadian disruption |
| Q46782445 | Effect of exogenous catecholamines on tumor necrosis factor alpha, interleukin-6, interleukin-10 and beta-endorphin levels following severe trauma |
| Q43211989 | Effects of glutamine on intestinal permeability and bacterial translocation in TPN-rats with endotoxemia |
| Q46442508 | Effects of hydroxyethyl starch on hepatic production of cytokines and activation of transcription factors in lipopolysaccharide-administered rats |
| Q40878773 | Effects of metoclopramide on the expression of metalloproteinases and interleukins in left colonic anastomoses. An experimental study. |
| Q36871151 | Efficacy and safety of active negative pressure peritoneal therapy for reducing the systemic inflammatory response after damage control laparotomy (the Intra-peritoneal Vacuum Trial): study protocol for a randomized controlled trial |
| Q43912083 | Expression of metalloproteinases and interleukins on anastomoses in septic rats |
| Q34429263 | General anesthesia delays the inflammatory response and increases survival for mice with endotoxic shock |
| Q87661492 | IFN-γ-producing NKT cells exacerbate sepsis by enhancing C5a generation via IL-10-mediated inhibition of CD55 expression on neutrophils |
| Q58377217 | Increase in the Production of Interleukin-6, Interleukin-10, and Interleukin-12 by Lipopolysaccharide-Stimulated Peritoneal Macrophages from Women with Endometriosis |
| Q26778888 | Inflammatory mediators in intra-abdominal sepsis or injury - a scoping review |
| Q35006972 | Methanol extract of Phellodendri cortex alleviates lipopolysaccharide-induced acute airway inflammation in mice |
| Q41603563 | Pharmacological blockade of CCR1 ameliorates murine arthritis and alters cytokine networks in vivo |
| Q43443337 | Plasma concentrations of pro- and anti-inflammatory cytokines and outcome prediction in elderly hip fracture patients |
| Q34582310 | Present concepts on the inflammatory modulators with special reference to cytokines |
| Q77383604 | Severe sepsis induces deficient interferon-gamma and interleukin-12 production, but interleukin-12 therapy improves survival in peritonitis |
| Q48013891 | The imbalance between regulatory and IL-17-secreting CD4+T cells in multiple-trauma rat |
Search more.